Recombinant HDL-Like Nanoparticles: A Specific Contrast Agent for MRI of Atherosclerotic Plaques
Journal of the American Chemical Society2004Vol. 126(50), pp. 16316–16317
Citations Over TimeTop 1% of 2004 papers
Abstract
A new contrast agent for MRI based on recombinant HDL-like nanoparticles has been prepared. It shows a great potential as a contrast agent for atherosclerotic plaques in a relative short time (24 h post-injection) as it is selective for the plaques and is an endogenous molecule. It also can distinguish between different types of plaques as the enhancement obtained is different, depending on plaque composition.
Related Papers
- Effect of Temperature on the Growth of Recombinant E.coli and on the Expression of Recombinant Protein(2002)
- Cyclic AMP and prostaglandins in periodontal disease.(1980)
- → SUPPRESSION OF THE FORMATION OF POLYGENOTYPIC RECOMBINANT COLONIES BY A maf MUTATION IN MATING WITH HfrH(1979)3 cited
- [Expression of recombinant human ZP3 protein using the baculovirus expression system].(2014)
- → Recombinant Proteins in Diagnosis and Therapy(2009)